ArticleAddiction (Abingdon, England)2018
Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation.
Article in Addiction (Abingdon, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Identifying best modelling practices for tobacco control policy simulations: a systematic review and a novel quality assessment framework.Tobacco control · 2023Pooled it
- Is it cost-effective to provide internet-based interventions to complement the current provision of smoking cessation services in the Netherlands? An analysis based on the EQUIPTMOD.Addiction (Abingdon, England) · 2018Pooled it
- Association Between Smoking Cessation Treatment and Healthcare Costs in a Single-Payer Public Healthcare System.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023Article
- A cost-utility analysis of the impact of electronic nicotine delivery systems on health care costs and outcomes in Canada.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2022Article
- Trends in Utilization, Spending, and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis, 1991-2015.American health & drug benefits · 2018Article
- Cost-effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD.Addiction (Abingdon, England) · 2018Article
- A utility of model input uncertainty analysis in transferring tobacco control-related economic evidence to countries with scarce resources: results from the EQUIPT study.Addiction (Abingdon, England) · 2018Article
- Assessment of cost-effective changes to the current and potential provision of smoking cessation services: an analysis based on the EQUIPTMOD.Addiction (Abingdon, England) · 2018Article
- Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation.Addiction (Abingdon, England) · 2018Article
- Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD.Addiction (Abingdon, England) · 2018Article
- Estimates of costs for modelling return on investment from smoking cessation interventions.Addiction (Abingdon, England) · 2018Article
- Estimates of effectiveness and reach for 'return on investment' modelling of smoking cessation interventions using data from England.Addiction (Abingdon, England) · 2018Article
- Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD.Addiction (Abingdon, England) · 2018Article
- An examination of user costs in relation to smokers using a cessation service based in the UK.BMC health services research · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
BACKGROUND AND
aimsAlthough clear benefits are associated with reducing smoking, there is increasing pressure on public health providers to justify investment in tobacco control measures. Decision-makers need tools to assess the Return on Investment (ROI)/cost-effectiveness of programmes. The EQUIPT project adapted an ROI tool for England to four European countries (Germany, the Netherlands, Spain and Hungary). EQUIPTMOD, the economic model at the core of the ROI tool, is designed to assess the efficiency of packages of smoking cessation interventions. The objective of this paper is to describe the methods for EQUIPTMOD and identify key outcomes associated with continued and cessation of smoking.
methodsEQUIPTMOD uses a Markov model to estimate life-time costs, quality-adjusted life years (QALYs) and life years associated with a current and former smoker. It uses population data on smoking prevalence, disease prevalence, mortality and the impact of smoking combined with associated costs and utility effects of disease. To illustrate the tool's potential, costs, QALYs and life expectancy were estimated for the average current smoker for five countries based on the assumptions that they continue and that they cease smoking over the next 12 months. Costs and effects were discounted at country-specific rates.
resultsFor illustration, over a life-time horizon, not quitting smoking within the next 12 months in England will reduce life expectancy by 0.66, reduce QALYs by 1.09 and result in £4961 higher disease-related health care costs than if the smoker ceased smoking in the next 12 months. For all age-sex categories, costs were lower and QALYs higher for those who quit smoking in the 12 months than those who continued.
conclusionsEQUIPTMOD facilitates assessment of the cost effectiveness of smoking cessation strategies. The demonstrated results indicate large potential benefits from smoking cessation at both an individual and population level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.